Evidence map›Paper›PMID 20490908›Full record

Trial reportAIDS and behavior2010

Use of non-occupational post-exposure prophylaxis does not lead to an increase in high risk sex behaviors in men who have sex with men participating in the EXPLORE trial.

Deborah Donnell, Matthew J Mimiaga, Kenneth Mayer, Margaret Chesney, Beryl Koblin, Thomas Coates

Open access · hybridAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in AIDS and behavior, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Brief Report: Rethinking Data Collection for HIV Prevention Trials.Journal of acquired immune deficiency syndromes (1999) · 2016
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 1 country.

Deborah DonnellVaccine and Infectious Disease Institute, Fred Hutchinson Cancer Research Ctr, Seattle, WA 98109, USA. deborah@scharp.org
Matthew J Mimiaga
Kenneth Mayer
Margaret Chesney
Beryl Koblin
Thomas Coates
Fenway Health · USInfectious Disease Research Institute · USMassachusetts General Hospital · USNew York Blood Center · USUniversity of California, Los Angeles · USUniversity of California, San Francisco · US

Funding

HIV PREVENTION TRIALS NETWORK LEADERSHIP GROUPU01AI046749 · NIAID · FAMILY HEALTH INTERNATIONAL · PI CATES, WILLARD · 1999 to 2005
$73.5M
Leadership for HIV/AIDS Clinical Trials Networks; HIV Prevention Trials NetworkU01AI068617 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI DONNELL, DEBORAH J · 2006 to 2010
$28.8M
THE ZIMBABWE-SAN FRANCISCO HIV PREVENTION TRIALS UNITU01AI047995 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHIPATO, TSUNGAI · 2000 to 2006
$27.2M
HIV PREVENTION TRIAL UNITSU01AI048040 · NIAID · FENWAY COMMUNITY HEALTH CENTER · PI MAYER, KENNETH H · 2000 to 2007
$11.5M
STDS AND HETEROSEXUAL BRIDGING AMONG MEN WHO HAVE SEXU01AI047981 · NIAID · UNIVERSITY OF WASHINGTON · PI CELUM, CONNIE L · 2000 to 2006
$8.5M
HIV PREVENTION TRIAL UNIT (PRIDE NYC PROGRAM)U01AI048016 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI EL-SADR, WAFAA M. · 2000 to 2006
$7.8M
DOMESTIC MASTER CONTRACT FOR HIV VACCINE EFFICACY TRIALSN01AI035176 · NIAID · ABT ASSOCIATES, INC. · PI SEAGE, GEORGE R · 1993 to 2000
$2.5M
STATISTICAL &CLINICAL COORDINATING CENTER (SC)N01AI045200 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI SELF, STEVEN G. · 1994 to 2000
$853k
INTNL.VACC.EFFICACY TRIALS MASTER CONTRACT (IMC)N01AI035173 · NIAID · FAMILY HEALTH INTERNATIONAL · PI CATES, WILLARD · 1993 to 2000
$0k
NCI NIH HHS N01 CA035176NIAID NIH HHS N01 AI035173NIAID NIH HHS N01 AI045200NIAID NIH HHS N01 AI35173NIAID NIH HHS N01 AI35176NIAID NIH HHS N01 AI45200NIAID NIH HHS U01 AI046749NIAID NIH HHS U01 AI047981NIAID NIH HHS U01 AI047995NIAID NIH HHS U01 AI048016NIAID NIH HHS U01 AI048040NIAID NIH HHS U01 AI068617NIAID NIH HHS U01 AI46749NIAID NIH HHS U01 AI47981NIAID NIH HHS U01 AI47995NIAID NIH HHS U01 AI48016NIAID NIH HHS U01 AI48040
6 · The paper itself

Abstract

Non-occupational post-exposure prophylaxis (nPEP) use is an HIV prevention strategy that has been recommended by the CDC to prevent HIV infection after a high risk sexual exposure since 1997. In a behavioral intervention trial of 4,295 MSM we assessed perceptions and use of nPEP over 4 years in six cities across the United States. Overall, 1.9% of MSM reported use of nPEP prior to enrollment, and 6.3% at least once during the trial. Awareness of nPEP was reported by 47.5%, with higher awareness in two sites with funded nPEP programs. Three seroconversions occurred in the 384 visits where nPEP courses were reported, with no effect of nPEP on risk of HIV acquisition in this cohort (hazard ratio = 0.91, 95% confidence interval [0.29, 2.86]). NPEP users were a riskier group: increased odds of nPEP use were observed in association with multiple partners and unprotected receptive and insertive anal sex with HIV infected partners and partners with unknown HIV status. NPEP use was also associated with use of illicit drugs (injection drugs, crack cocaine, hallucinogens, and amphetamines). Importantly, willingness to use nPEP after high risk sex was associated with lower odds of high risk sex. After an episode of nPEP use, nPEP users remained more likely to report high risk sex than those in this cohort who had not previously used nPEP. However, within the subset of people who had previously reported high risk sex, previous nPEP use was not associated with higher odds of high risk sex, thus allaying fears that availability of nPEP would lead to an increase in high risk sex.

Indexed as

Homosexuality, MalePost-Exposure ProphylaxisAdolescentAdultCounselingFollow-Up StudiesHealth Knowledge, Attitudes, PracticeHIV InfectionsHumansLongitudinal StudiesMaleMiddle AgedRisk Reduction BehaviorRisk-TakingSexual PartnersSubstance Abuse, Intravenous

Identifiers

PMID20490908
PMCPMC2944957
OpenAlexW2138964638

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.